Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).
Win T, Screaton NJ, Porter JC, Ganeshan B, Maher TM, Fraioli F, Endozo R, Shortman RI, Hurrell L, Holman BF, Thielemans K, Rashidnasab A, Hutton BF, Lukey PT, Flynn A, Ell PJ, Groves AM. Win T, et al. Among authors: shortman ri. Eur J Nucl Med Mol Imaging. 2018 May;45(5):806-815. doi: 10.1007/s00259-017-3917-8. Epub 2018 Jan 16. Eur J Nucl Med Mol Imaging. 2018. PMID: 29335764 Free PMC article. Clinical Trial.
Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients.
Win T, Thomas BA, Lambrou T, Hutton BF, Screaton NJ, Porter JC, Maher TM, Endozo R, Shortman RI, Afaq A, Lukey P, Ell PJ, Groves AM. Win T, et al. Among authors: shortman ri. Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):337-42. doi: 10.1007/s00259-013-2514-8. Epub 2013 Aug 14. Eur J Nucl Med Mol Imaging. 2014. PMID: 23942907 Free PMC article.
18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials.
Win T, Lambrou T, Hutton BF, Kayani I, Screaton NJ, Porter JC, Maher TM, Endozo R, Shortman RI, Lukey P, Groves AM. Win T, et al. Among authors: shortman ri. Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):521-8. doi: 10.1007/s00259-011-1986-7. Epub 2011 Nov 30. Eur J Nucl Med Mol Imaging. 2012. PMID: 22258710 Clinical Trial.
19 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page